Real world evidence on treatment of chronic spontaneous urticaria with omalizumab: Preliminary data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real world evidence on treatment of chronic spontaneous urticaria with omalizumab: Preliminary data

Published:2020-06-07 Issue:4 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Corrao Salvatore¹²,Prestigiacomo Maria A.¹,Angileri Rosa G.¹,Natoli Giuseppe¹^ORCID,Argano Christiano¹

Affiliation:

1. Department of Internal Medicine National Relevance and High Specialization Hospital Trust A.R.N.A.S. Civico, Di Cristina, Benfratelli Palermo Italy

2. Università di Palermo, Dipartimento di Promozione della Salute, Materno Infantile, Medicina Interna e Specialistica di Eccellenza “G. D'Alessandro”, PROMISE Palermo Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.13458

Reference5 articles.

1. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase

2. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria

3. Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice

4. Long-term management of chronic spontaneous urticaria with omalizumab

5. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP